Indication
Treatment of activated phosphoinositide 3-kinase delta (P13Kδ) syndrome (APDS) in adult and paediatric patients 12 years of age and older.
Medicine details
- Medicine name:
- leniolisib (Joenja)
- SMC ID:
- SMC2836
- Pharmaceutical company
- Pharming Group NV
- BNF chapter
- Nutrition and blood
- Submission type
- Ultra-orphan initial assessment
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC